Cur Aegis Technologies's - CRGS market analysis on 17th January 2021

Transaction Date	Recipient	Shares	Type	Price	Value
8th September 2020	B Thomas Golisano	829	Bona fide gift	$76.54	$63,451.66
28th August 2020	B Thomas Golisano	45,000	Open or private purchase	$150,000.00	$6,750,000,000.00
2nd July 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00
3rd June 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00
2nd June 2020	B Thomas Golisano	937	Bona fide gift	$72.08	$67,538.96
31st March 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00
28th February 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00
27th February 2020	B Thomas Golisano	745	Bona fide gift	$90.22	$67,213.90
29th January 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00
7th January 2020	B Thomas Golisano	37,500	Open or private purchase	$125,000.00	$4,687,500,000.00

Cur Aegis Technologies

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.

Aegis Technologies, Inc. develops and markets advanced technologies in the areas of safety, wellness and power. It operates through the following segments: CURA and Aegis. The CURA segment involves in advanced fatigue management products. The Aegis segment develops advanced hydraulic pump and motor designs.

Ticker: CRGS

Sector: Producer Manufacturing

Industry: Auto Parts: OEM

SEC Central Index Key (CIK): 1063197

Employees: 7

Exchange: US OTC

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis